Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, to Healthy Male and Female Volunteers, With an Intra-individual Comparison to Moxifloxacin in a Subset of Volunteers
Clinical trial NCT02264015 · COMPLETED
Trial details
- NCT number
- NCT02264015
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2004-05-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.